CISSSL - Hopital Pierre-Le Gardeur

Terrebonne, Quebec J6V 2H2

1 studies enrolling now · 3 studies all time

What they study most

Atrial Fibrillation, Cardiovascular Diseases, Coronary Artery Disease, Coronary Disease, Heart Diseases, Heart Failure, Heart Failure With Reduced Ejection Fraction, Myocardial Ischemia, Prevention of Stroke or Systemic Embolism

Studies at this site

• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction — Recruiting now
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed